CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.06B
This Quarter Return
+9.19%
1 Year Return
+31.81%
3 Year Return
+205.04%
5 Year Return
–
10 Year Return
–
AUM
$709M
AUM Growth
+$709M
(-9.9%)
Cap. Flow
-$72.4M
Cap. Flow
% of AUM
-10.22%
Top 10 Holdings %
Top 10 Hldgs %
37.25%
Holding
452
New
12
Increased
93
Reduced
281
Closed
40
Top Buys
| 1 |
NVIDIA
NVDA
|
$40.6M |
| 2 |
Apple
AAPL
|
$9.08M |
| 3 |
Applied Materials
AMAT
|
$5.39M |
| 4 |
Arista Networks
ANET
|
$5.26M |
| 5 |
Amphenol
APH
|
$5.14M |
Top Sells
| 1 |
Amgen
AMGN
|
$8.02M |
| 2 |
Adobe
ADBE
|
$7.95M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$7.6M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$6.84M |
| 5 |
Lam Research
LRCX
|
$5.23M |
Sector Composition
| 1 | Technology | 43.87% |
| 2 | Healthcare | 22.25% |
| 3 | Consumer Discretionary | 12.69% |
| 4 | Communication Services | 10.44% |
| 5 | Consumer Staples | 3.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
TAL Education Group
TAL
$6.38B
| $1.02M | 0.14% |
96,000
+91,900
| +2,241% | +$981K |
|
102
Amer Sports
AS
$21.4B
| $999K | 0.14% |
79,470
-13,830
| -15% | -$174K |
|
103
Futu Holdings
FUTU
$25.7B
| $984K | 0.14% |
+15,000
| New | +$984K |
|
104
Vaxcyte
PCVX
$4.08B
| $965K | 0.14% |
12,781
-8,059
| -39% | -$609K |
|
105
iShares Gold Trust Micro
IAUM
$3.53B
| $951K | 0.13% |
41,000
+9,000
| +28% | +$209K |
|
106
GraniteShares Gold Shares
BAR
$1.16B
| $941K | 0.13% |
41,000
+9,000
| +28% | +$207K |
|
107
BioNTech
BNTX
$24.2B
| $932K | 0.13% |
11,599
-7,101
| -38% | -$571K |
|
108
Ascendis Pharma
ASND
$12B
| $928K | 0.13% |
6,804
-4,216
| -38% | -$575K |
|
109
Roivant Sciences
ROIV
$8.49B
| $917K | 0.13% |
86,789
-68,121
| -44% | -$720K |
|
110
JPMorgan Chase
JPM
$817B
| $900K | 0.13% |
4,449
-1,465
| -25% | -$296K |
|
|
ITCI
111
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $849K | 0.12% |
12,403
-6,210
| -33% | -$425K |
|
|
112
Lam Research
LRCX
$122B
| $838K | 0.12% |
786
-4,905
| -86% | -$5.23M |
|
113
Honeywell
HON
$137B
| $836K | 0.12% |
3,915
+973
| +33% | +$208K |
|
114
Berkshire Hathaway Class B
BRK.B
$1.08T
| $826K | 0.12% |
2,031
-601
| -23% | -$244K |
|
115
Ionis Pharmaceuticals
IONS
$8.75B
| $817K | 0.12% |
17,150
-10,877
| -39% | -$518K |
|
116
Starbucks
SBUX
$99.9B
| $802K | 0.11% |
10,306
+1,703
| +20% | +$133K |
|
117
Exxon Mobil
XOM
$489B
| $800K | 0.11% |
6,948
-1,077
| -13% | -$124K |
|
118
Analog Devices
ADI
$121B
| $795K | 0.11% |
3,483
+246
| +8% | +$56.2K |
|
|
BPMC
119
DELISTED
Blueprint Medicines
BPMC
| $793K | 0.11% |
7,355
-4,422
| -38% | -$477K |
|
120
Intel
INTC
$105B
| $793K | 0.11% |
25,596
-1,940
| -7% | -$60.1K |
|
121
Jazz Pharmaceuticals
JAZZ
$7.83B
| $790K | 0.11% |
7,405
-4,593
| -38% | -$490K |
|
122
Halozyme
HALO
$8.66B
| $783K | 0.11% |
14,953
-9,395
| -39% | -$492K |
|
123
Exelixis
EXEL
$10.1B
| $769K | 0.11% |
34,222
-24,077
| -41% | -$541K |
|
124
Revolution Medicines
RVMD
$7.49B
| $752K | 0.11% |
19,383
-12,254
| -39% | -$476K |
|
125
Cytokinetics
CYTK
$5.75B
| $730K | 0.1% |
13,471
-6,299
| -32% | -$341K |
|